CONMED Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,372	1,375	1,307	1,245	1,045	1,011
Revenue Growth	3.42%	5.18%	5.00%	19.06%	3.45%	17.18%
Cost of Revenue	606.35	624.25	573.98	568.5	474.23	442.6
Gross Profit	765.31	750.48	733.03	676.25	571.25	568.04
Selling, General & Admin	594.35	591.97	478.28	503.04	454.04	414.75
Research & Development	60.63	55.88	54.43	52.6	47.15	43.57
Other Operating Expenses	-	0.42	-	-	112.01	1.13
Total Operating Expenses	654.99	648.27	532.71	555.64	613.2	459.45
Operating Income	110.32	102.2	200.33	120.6	-41.96	108.59
Interest Expense	-29.92	-31.09	-37.3	-39.78	-28.91	-35.49
Total Non-Operating Income (Expense)	-29.92	-31.09	-37.3	-39.78	-28.91	-35.49
Pretax Income	80.4	71.12	163.03	80.83	-70.86	73.11
Provision for Income Taxes	26.73	24.06	30.61	16.37	9.72	10.56
Net Income	53.67	47.06	132.42	64.46	-80.58	62.54
Net Income to Common	56.5	47.06	132.42	64.46	-80.58	62.54
Net Income Growth	-48.73%	-64.47%	105.44%	-	-	557.16%
Shares Outstanding (Basic)	31	31	31	31	30	29
Shares Outstanding (Diluted)	31	31	31	32	30	32
Shares Change	-1.32%	-0.00%	-1.26%	5.02%	-6.75%	9.34%
EPS (Basic)	1.85	1.52	4.29	2.10	-2.68	2.14
EPS (Diluted)	1.85	1.51	4.25	2.04	-2.68	1.94
EPS Growth	-47.59%	-64.47%	108.33%	-	-	506.25%
Free Cash Flow	134.46	150.88	153.88	106.32	11.58	96.9
Free Cash Flow Growth	-9.29%	-1.95%	44.74%	818.10%	-88.05%	88.10%
Free Cash Flow Per Share	4.38	4.84	4.94	3.37	0.39	3.01
Dividends Per Share	0.200	0.600	0.800	0.800	0.800	0.800
Dividend Growth	-75.00%	-25.00%	0%	0%	0%	0%
Gross Margin	55.79%	54.59%	56.08%	54.33%	54.64%	56.21%
Operating Margin	8.04%	7.43%	15.33%	9.69%	-4.01%	10.74%
Profit Margin	3.91%	3.42%	10.13%	5.18%	-7.71%	6.19%
FCF Margin	9.80%	10.98%	11.77%	8.54%	1.11%	9.59%
EBITDA	185.66	176.49	272.18	192.48	27.56	179.33
EBITDA Margin	13.54%	12.84%	20.82%	15.46%	2.64%	17.74%
EBIT	110.32	102.2	200.33	120.6	-41.96	108.59
EBIT Margin	8.04%	7.43%	15.33%	9.69%	-4.01%	10.74%
Effective Tax Rate	33.25%	33.83%	18.77%	20.25%	-13.72%	14.45%

SEC Filings: 10-K · 10-Q